Foreign media reports that Wedbush analyst Dan Ives believes AI commercialization is approaching a new phase, and a Mag 7 stock he considers "undervalued" still has approximately 30% upside potential. This assessment reflects market attention to the pace of AI monetization and continues to fuel discussion surrounding large-cap tech stocks.

AI commercialization enters a new stage

Ives stated that AI may enter the commercialization phase in the coming months. In other words, market focus on AI is shifting from model capabilities to revenue realization.

He believes this change will lead investors to reassess the valuations of large tech companies. Companies with strengths in AI infrastructure, cloud services, and software distribution, in particular, are likely to attract more funding.

Mag 7 valuation divergence widens

The Mag 7 stock that Ives specifically mentioned is still considered "undervalued." His target upside of approximately 30% indicates his optimism about the stock's future performance.

This kind of assessment also indicates that the market does not view the Mag 7 as a single group of assets. The extent to which they benefit from AI, the pace of profit generation, and the intensity of capital expenditure are widening the valuation gap between these companies.

The market continues to focus on earnings realization.

For investors, the focus going forward is not so much on the AI concept itself, but rather on when companies will be able to translate their technological advantages into revenue. If commercialization accelerates, discussions about the valuations of related tech stocks will continue to intensify.

Ives's view also echoes Wall Street's main assessment of AI deals: the market is looking for companies that can truly turn AI into cash flow.